# Remote ECG Monitoring Post TAVI

Study · id `cardio:ct-nct07521800` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07521800](<https://clinicaltrials.gov/study/NCT07521800>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07521800

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 250 participants.

## Technical summary

Registry record NCT07521800. Randomized; no masking; primary purpose treatment. Start 2023-12-01 (actual); primary completion 2027-02-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 250 participants (planned count; ClinicalTrials.gov record NCT07521800, source copy `cardio:ctgov-nct07521800-2026-04-13`, retrieved 2026-10-26)
- Started: 2023-12-01 (actual) (ClinicalTrials.gov record NCT07521800, source copy `cardio:ctgov-nct07521800-2026-04-13`, retrieved 2026-10-26)
- Primary completion: 2027-02-01 (anticipated) (ClinicalTrials.gov record NCT07521800, source copy `cardio:ctgov-nct07521800-2026-04-13`, retrieved 2026-10-26)
- Completion: 2028-02-01 (anticipated) (ClinicalTrials.gov record NCT07521800, source copy `cardio:ctgov-nct07521800-2026-04-13`, retrieved 2026-10-26)
- Countries: Italy; Poland (ClinicalTrials.gov record NCT07521800, source copy `cardio:ctgov-nct07521800-2026-04-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07521800-2026-04-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Remote ECG Monitoring Post TAVI
- Acronym: DRAGON-TAVI
- Condition: TAVI(Transcatheter Aortic Valve Implantation)
- Condition: Remote Monitoring
- Condition: Arrythmia
- Condition: Atrial Fibrillation (AF)
- Condition: Atrioventricular Block
- Intervention (Device): Remote ECG monitoring
- Intervention (Device): Standard Care (in control arm)
- Lead sponsor: Medical University of Silesia
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Heart block (`cardio:heart-block`)
- Registry lists this organization as the lead sponsor: Medical University of Silesia (`cardio:org-medical-university-of-silesia`)

## Provenance

Content hash: 1fe8daba1c018d0ca6ca05dad2253062e8756fbcd79f70752e3ce4cb8eecbb48
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
